Showing results (621-630 of 794) with videos related to
Sort By:
Pageof 80
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 25, 2025
Targeting NAT10 attenuates homologous recombination via destabilizing DNA:RNA hybrids and overcomes PARP inhibitor resistance in cancersZhu Xu, Mingming Zhu, Longpo Geng, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2009
Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populationsXiao-Mu Wu, Chaodong Wang, Kun-Nan Zhang, et al.European Journal of Medical Research|November 17, 2023
Carpets with visual cues can improve gait in Parkinson's disease patients: may be independent of executive functionZe-Di Hu, Shi-Guo Zhu, Jie-Fan Huang, et al.Nature Structural & Molecular Biology|September 22, 2023
PARylated PDHE1α generates acetyl-CoA for local chromatin acetylation and DNA damage repairJun Zhang, Feng Chen, Yuan Tian, et al.Autophagy|January 20, 2017
PTK2-mediated degradation of ATG3 impedes cancer cells susceptible to DNA damage treatmentKe Ma, Wan Fu, Ming Tang, et al.Pharmacology|January 4, 2021
Tanshinone IIA Ameliorates Inflammation Response in Osteoarthritis via Inhibition of miR-155/FOXO3 AxisBiao Zhou, Lin-Hui Li, Li-Ming Tan, et al.Science China. Life Sciences|July 26, 2022
The repression of oncoprotein SET by the tumor suppressor p53 reveals a p53-SET-PP2A feedback loop for cancer therapyHan Yao, Wenbin Xu, Yajing Liu, et al.Bioorganic Chemistry|March 10, 2021
Bioactive prenylated C6-C3 derivatives from the stems and leaves of Illicium fargesiiGuo-Zhu Su, Ru-Bing Wang, Yong Li, et al.Oncology Research|July 28, 2017
miR-133a-3p Targets SUMO-Specific Protease 1 to Inhibit Cell Proliferation and Cell Cycle Progress in Colorectal CancerGuo-Qiang Zhou, Fu Han, Zhi-Liang Shi, et al.Neuropharmacology|January 16, 2007
Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targetsDi Zhang, Anita Saraf, Teodozyi Kolasa, et al.Pageof 80